Summary
Khanh Huynh is a biotech entrepreneur and scientist with 11 years of professional experience who co-founded Bioburst.io and leads Kiramax Laboratories, building recombinant antibody discovery platforms for conventional and single-domain antibodies. With a PhD in Biochemistry, Biophysics and Molecular Biology and a background leading molecular biology teams at Cell Signaling Technology, he combines deep hands-on expertise in antibody engineering, protein production, CRISPR, and NGS with practical product-driven leadership. He prioritizes empowering teams to execute independently and values open scientific discourse, reflecting a management style that favors trust, initiative, and removing obstacles to productivity. Khanh’s trajectory spans academia and industry—from Harvard and MGH research roles to commercializing antibody discovery—demonstrating an ability to translate fundamental research into scalable biotech platforms.
11 years of coding experience
University of Minnesota Twin Cities
English, Vietnamese